Terms: = Leukemia AND RBM15, Q96T37, 64783, ENSG00000162775, OTT, OTT1 AND Treatment
11 results:
1. Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic leukemia in Canada.
Lachaine J; Guinan K; Aw A; Banerji V; Fleury I; Owen C
Curr Oncol; 2023 Apr; 30(5):4483-4498. PubMed ID: 37232797
[TBL] [Abstract] [Full Text] [Related]
2. [Acute leukemia of infants and neonates].
Eguchi M
Rinsho Ketsueki; 2021; 62(8):1308-1318. PubMed ID: 34497221
[TBL] [Abstract] [Full Text] [Related]
3. Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic leukemia in Canada.
Lachaine J; Beauchemin C; Guinan K; Thebault P; Aw A; Banerji V; Fleury I; Owen C
Curr Oncol; 2021 Jan; 28(1):332-345. PubMed ID: 33435341
[No Abstract] [Full Text] [Related]
4. Novel rotatable tabletop for total-body irradiation using a linac-based VMAT technique.
Losert C; Shpani R; Kießling R; Freislederer P; Li M; Walter F; Niyazi M; Reiner M; Belka C; Corradini S
Radiat Oncol; 2019 Dec; 14(1):244. PubMed ID: 31888680
[TBL] [Abstract] [Full Text] [Related]
5. [Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia].
Tamefusa K; Fukutake K; Ishida H; Tamura A; Endo M; Hamamoto K; Koga Y; Yamada M; Kanamitsu K; Fujiwara K; Washio K; Shimada A
Rinsho Ketsueki; 2019; 60(2):99-105. PubMed ID: 30842387
[TBL] [Abstract] [Full Text] [Related]
6. NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy.
Roussy M; Bilodeau M; Jouan L; Tibout P; Laramée L; Lemyre E; Léveillé F; Tihy F; Cardin S; Sauvageau C; Couture F; Louis I; Choblet A; Patey N; Gendron P; Duval M; Teira P; Hébert J; Wilhelm BT; Choi JK; Gruber TA; Bittencourt H; Cellot S
Genes Chromosomes Cancer; 2018 Jun; 57(6):311-319. PubMed ID: 29427526
[TBL] [Abstract] [Full Text] [Related]
7. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.
de Rooij JD; Branstetter C; Ma J; Li Y; Walsh MP; Cheng J; Obulkasim A; Dang J; Easton J; Verboon LJ; Mulder HL; Zimmermann M; Koss C; Gupta P; Edmonson M; Rusch M; Lim JY; Reinhardt K; Pigazzi M; Song G; Yeoh AE; Shih LY; Liang DC; Halene S; Krause DS; Zhang J; Downing JR; Locatelli F; Reinhardt D; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M; Gruber TA
Nat Genet; 2017 Mar; 49(3):451-456. PubMed ID: 28112737
[TBL] [Abstract] [Full Text] [Related]
8. Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study.
de Rooij JD; Masetti R; van den Heuvel-Eibrink MM; Cayuela JM; Trka J; Reinhardt D; Rasche M; Sonneveld E; Alonzo TA; Fornerod M; Zimmermann M; Pigazzi M; Pieters R; Meshinchi S; Zwaan CM; Locatelli F
Blood; 2016 Jun; 127(26):3424-30. PubMed ID: 27114462
[TBL] [Abstract] [Full Text] [Related]
9. Detection of rbm15-MKL1 fusion was useful for diagnosis and monitoring of minimal residual disease in infant acute megakaryoblastic leukemia.
Takeda A; Shimada A; Hamamoto K; Yoshino S; Nagai T; Fujii Y; Yamada M; Nakamura Y; Watanabe T; Watanabe Y; Yamamoto Y; Sakakibara K; Oda M; Morishima T
Acta Med Okayama; 2014; 68(2):119-23. PubMed ID: 24743787
[TBL] [Abstract] [Full Text] [Related]
10. NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern.
de Rooij JD; Hollink IH; Arentsen-Peters ST; van Galen JF; Berna Beverloo H; Baruchel A; Trka J; Reinhardt D; Sonneveld E; Zimmermann M; Alonzo TA; Pieters R; Meshinchi S; van den Heuvel-Eibrink MM; Zwaan CM
Leukemia; 2013 Dec; 27(12):2280-8. PubMed ID: 23531517
[TBL] [Abstract] [Full Text] [Related]
11. Biological effects of decreasing rbm15 on chronic myelogenous leukemia cells.
Yang Y; Wang S; Zhang Y; Zhu X
Leuk Lymphoma; 2012 Nov; 53(11):2237-44. PubMed ID: 22497198
[TBL] [Abstract] [Full Text] [Related]
